Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy

Acta Ophthalmologica

Volumn 89, Issue 7, 2011, Pages 634-640

  Yeh, Po Ting ^a   Yang, Chang Hao ^a,b   Yang, Chung May ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bevacizumab (Avastin); diabetic retinopathy; postvitrectomy; recurrent vitreous haemorrhage

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; SILICONE OIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DIABETIC RETINOPATHY; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; IRIS RUBEOSIS; LASER COAGULATION; LENSECTOMY; MALE; NEOVASCULAR GLAUCOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RETINAL CRYOTHERAPY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; VITRECTOMY; VITREOUS CLEAR UP TIME; VITREOUS HEMORRHAGE; VITREOUS REBLEEDING RATE;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; ENDOTAMPONADE; FEMALE; FLUOROCARBONS; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PRONE POSITION; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 80155151155     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01821.x     Document Type: Article

References (26)

1. Abrams GW, &, Williams GA, (1987): "En bloc" excision of diabetic membranes. Am J Ophthalmol 103: 302-308.
2. Avery RL, Pearlman J, Pieramici DJ, et al., (2006): Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113: 1695.
3. Bakri SJ, Snyder MR, Reid JM, Pulido JS, &, Singh RJ, (2007): Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114: 855-859. (Pubitemid 46635858)
4. Blumenkranz M, Gardner T, &, Blankenship G, (1986): Fluid-gas exchange and photocoagulation after vitrectomy. Indications, technique, and results. Arch Ophthalmol 104: 291-296. (Pubitemid 16119634)
5. Bodanowitz S, Kir N, &, Hesse L, (1997): Silicone oil for recurrent vitreous hemorrhage in previously vitrectomized diabetic eyes. Ophthalmologica 211: 219-222. (Pubitemid 27248497)
6. Ficker L, Meredith TA, Gardner S, &, Wilson LA, (1990): Cefazolin levels after intravitreal injection. Effects of inflammation and surgery. Invest Ophthalmol Vis Sci 31: 502-505. (Pubitemid 20117066)
7. Heiduschka P, Fietz H, Hofmeister S, et al., (2007): Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48: 2814-2823. (Pubitemid 351261238)
8. Isaacs TW, &, Barry C, (2006): Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin). Clin Experiment Ophthalmol 34: 802-803. (Pubitemid 44650158)
9. Koch FH, Kreiger AE, Spitznas M, Glasgow B, Foos RY, &, Yoshizumi MO, (1995): Pars plana incisions of four patients: histopathology and electron microscopy. Br J Ophthalmol 79: 486-493.
10. Kreiger AE, (1993): Wound complications in pars plana vitrectomy. Retina 13: 335-344. (Pubitemid 24010692)
11. Mieler WF, &, Wolf MD, (1994): Management of postvitrectomy diabetic vitreous hemorrhage. In:, Lewis H, &, Ryan SJ, (ed.) Medical and surgical retina: advances, controversies, and management. St Louis, Missouri: Mosby 330-340.
12. Minnella AM, Savastano CM, Ziccardi L, Scupola A, Falsini B, &, Balestrazzi E, (2008): Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy. Acta Ophthalmol 86: 683-687.
13. Mosesson MW, (2005): Fibrinogen and fibrin structure and functions. J Thromb Haemost 3: 1894-1904. (Pubitemid 41716577)
14. Neely KA, Scroggs MW, &, McCuen BW II, (1998): Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes. Am J Ophthalmol 126: 82-90. (Pubitemid 28341222)
15. Nussenblatt RB, Palestine AG, Chan CC, &, Roberge F, (1985): Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92: 467-471. (Pubitemid 15034518)
16. Oshima Y, Sakaguchi H, Gomi F, &, Tano Y, (2006): Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 142: 155-158.
17. Ramsay WJ, Ramsay RC, Purple RL, &, Knobloch WH, (1977): Involutional diabetic retinopathy. Am J Ophthalmol 84: 851-858. (Pubitemid 8267040)
18. Ruiz-Moreno JM, Montero JA, Lugo F, Amat P, &, Staicu C, (2008): Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmol 86: 231-232.
19. Sawa H, Ikeda T, Matsumoto Y, Niiya A, &, Kinoshita S, (2000): Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol 44: 154-160. (Pubitemid 30133199)
20. Schachat AP, Oyakawa RT, Michels RG, &, Rice TA, (1983): Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 90: 522-530.
21. Steel DH, Habib MS, Park S, Hildreth AJ, &, Owen RI, (2008): Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography. Ophthalmology 115: 525-532. (Pubitemid 351305330)
22. Terasaki H, Miyake Y, &, Awaya S, (1997): Fluorescein angiography of peripheral retina and pars plana during vitrectomy for proliferative diabetic retinopathy. Am J Ophthalmol 123: 370-376. (Pubitemid 27123044)
23. West JF, &, Gregor ZJ, (2000): Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 84: 822-825. (Pubitemid 30599084)
24. Yang CM, Yeh PT, &, Yang CH, (2007): Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 114: 710-715.
25. Yang L, Lai CC, Chen TL, Wu WC, Chen KJ, Hwang YS, &, Kuo YH, (2008): Intravitreal bevacizumab for recurrent vitreous hemorrhage in postvitrectomized eyes. Clin Experiment Ophthalmol 36 (Suppl. 1): A575.
26. Yeh PT, Yang CM, Yang CH, &, Huang JS, (2005): Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology 112: 2095-2102.